ARMP

Armata Pharmctcl

• TipRanks·5d ago

  Armata announces two new patents covering bacteriophage programs

• TipRanks·09/27 14:35

  JonesTrading Reaffirms Their Buy Rating on Armata Pharmaceuticals (ARMP)

• Benzinga·09/23 21:05

  12 Health Care Stocks Moving In Wednesday's After-Market Session

• Benzinga·09/23 16:12

  Armata Pharmaceuticals Stock Slides after Pentagon Funding Fuels Phase 3 Push for Anti-Bacterial Program

• Dow Jones·09/23 15:04

  Armata Pharmaceuticals Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

• Benzinga·09/23 14:54

  HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $15 Price Target

• Dow Jones·09/23 11:45

  Armata Gets $3.7M in Additional Funding From Defense Dept. for Bacterial Infection Treatment

• TipRanks·09/23 11:28

  Armata secures new U.S. funding for AP-SA02 Phase 3

• Benzinga·09/23 11:09

  Armata Pharmaceuticals Receives Additional $3.7M In Non-dilutive Funds From US Department Of War For Phase 3 Development Program For AP-SA02

• TipRanks·09/23 11:05

  Armata Pharmaceuticals receives $3.7M in additional funding from DoW

• PR Newswire·09/23 11:00

  Armata Pharmaceuticals Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development

• TipRanks·09/22 10:40

  Analysts Offer Insights on Healthcare Companies: RxSight (RXST) and Armata Pharmaceuticals (ARMP)

• PR Newswire·09/21 11:00

  Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates

• Benzinga·09/14 21:06

  12 Health Care Stocks Moving In Monday's After-Market Session

• Dow Jones·09/14 12:47

  Armata Pharma Shares Rise on FDA Breakthrough Therapy Designation for Antibacterial Treatment